Research Papers:

The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers

Yunhai Li, Jing Huang, Jiazheng Sun, Shili Xiang, Dejuan Yang, Xuedong Ying, Mengqi Lu, Hongzhong Li and Guosheng Ren _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2017; 8:4501-4519. https://doi.org/10.18632/oncotarget.13885

Metrics: PDF 2232 views  |   HTML 3622 views  |   ?  


Yunhai Li1,2, Jing Huang1, Jiazheng Sun1, Shili Xiang1, Dejuan Yang1,2, Xuedong Ying1,2, Mengqi Lu1, Hongzhong Li1,2, Guosheng Ren1,2

1Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

2Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Correspondence to:

Hongzhong Li, email: [email protected]

Guosheng Ren, email: [email protected]

Keywords: proteasome alpha subunits, cancer, oncomine, TCGA, Kaplan-Meier plotter

Received: June 19, 2016     Accepted: December 01, 2016     Published: December 10, 2016


Proteasome alpha subunits (PSMAs) have been shown to participate in the malignant progression of human cancers. However, the expression patterns and prognostic values of individual PSMAs remain elusive in most cancers. In the present study, we investigated the mRNA expression levels of seven PSMAs in different kinds of cancers using Oncomine and The Cancer Genome Atlas (TCGA) databases. The prognostic significance of PSMAs was also determined by Kaplan-Meier Plotter and PrognScan databases. Combined with Oncomine and TCGA, the mRNA expression levels of PSMA1-7 were significantly upregulated in breast, lung, gastric, bladder and head and neck cancer compared with normal tissues. Moreover, only PSMA6 and PSMA5 were not overexpressed in colorectal and kidney cancer, respectively. In survival analyses based on Kaplan-Meier Plotter, PSMA1-7 showed significant prognostic values in breast, lung and gastric cancer. Furthermore, potential correlations between PSMAs and survival outcomes were also observed in ovarian cancer, colorectal cancer and melanoma by Kaplan-Meier Plotter and PrognScan. These data indicated that PSMAs might serve as novel biomarkers and potential therapeutic targets for multiple human cancers. However, further studies are needed to explore the detailed biological functions and molecular mechanisms involved in tumor progression.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 13885